Glucose-dependent insulinotropic polypeptide (GIP) is an incre- tin hormone that enhances meal-stimulated insulin secretion and has been shown to modulate glucagon secretion in a glucose- dependent manner to facilitate postprandial lipid clearance, and to regulate food intake (Christensen et al., 2011;Kim et al., 2007;Nauck and Meier, 2018)
This synergy is exemplified by transmembrane protein 164 (TMEM164), which promotes autophagy-dependent ferroptosis in NSCLC
Circana added that it believes the industry is at an inflection point in how these drugs, which include Ozempic, Wegovy and Saxenda, will shape spending patterns in the future
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 digital issues and online access to articles 135,68 per year only 11,31 per issue Rent or buy this article Prices vary by article type from$1.95 to$39.95 Prices may be subject to local taxes which are calculated during checkout References NCD Risk Factor Collaboration